A Pill Could Do Major Damage to 'Bad' Cholesterol

Merck's enlicitide could become first oral PCSK9 inhibitor approved by FDA
Posted Nov 10, 2025 7:48 AM CST
Updated Nov 15, 2025 5:50 AM CST
More News: Tech | World | News | Politics | Entertainment